Related Experiment Video
Updated: Feb 28, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Paclitaxel Encapsulated in Halloysite Clay Nanotubes for Intestinal and Intracellular Delivery
Raghuvara Yendluri1, Yuri Lvov2, Melgardt M de Villiers3
1Institute for Micromanufacturing, Louisiana Tech University, Ruston, Louisiana 71272.
Abstract:
Naturally formed halloysite tubules have a length of 1 μm and lumens with a diameter of 12-15 nm which can be loaded with drugs. Halloysite's biocompatibility allows for its safe delivering to cells at a concentration of up to 0.5 mg/mL. We encapsulated the anticancer drug paclitaxel in halloysite and evaluated the drug release kinetics in simulated gastric and intestinal conditions. To facilitate maximum drug release in intestinal tract, halloysite tubes were coated with the pH-responsive polymer poly(methacrylic acid-co-methyl methacrylate). Release kinetics indicated a triggered drug release pattern at higher pH, corresponding to digestive tract environment. Tablets containing halloysite, loaded with paclitaxel, as a compression excipient were formulated with drug release occurring at a sustained rate. In vitro anticancer effects of paclitaxel-loaded halloysite nanotubes were evaluated on human cancer cells. In all the treated cell samples, polyploid nuclei of different sizes and fragmented chromatin were observed, indicating a high therapeutic effect of halloysite formulated paclitaxel.
Related Concept Videos
Drugs that Stabilize Microtubules
Site-Targeted Drug Delivery Systems: Polymeric Carriers

